We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1898:HKEXChina Coal Energy Company Limited Analysis

Data as of 2026-03-11 - not real-time

HK$14.19

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

China Coal Energy (1898.HK) is trading at HK$14.19, comfortably above its 20‑day (HK$12.85), 50‑day (HK$11.69) and 200‑day (HK$10.36) moving averages, confirming a bullish price trend. Technical momentum is strong with a bullish MACD crossover and a high RSI of 70, indicating the stock is in overbought territory and approaching its resistance near HK$14.59. Fundamentally, the company offers an attractive dividend yield of 3.27% with a modest payout ratio of 43%, supported by solid cash (HK$85.9bn) and free cash flow generation. However, revenue has contracted by 23.8% year‑over‑year and the DCF‑derived fair value of HK$4.66 suggests the market price is significantly overvalued, reflected in a -15% upside/downside metric. The valuation appears cheap relative to peers (PE 11 vs industry 22) and the stock trades near its 52‑week high, but sector‑specific headwinds—environmental regulation and the global shift away from thermal coal—add downside pressure. Overall, the stock combines strong income potential with elevated valuation and sector risk, warranting a nuanced stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI at 70 indicating overbought conditions
  • Price near resistance level of HK$14.59
  • Large gap between market price and DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low PE relative to industry peers
  • Strong dividend yield and sustainable payout
  • Negative revenue growth but solid cash generation

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Exposure to declining thermal coal demand
  • Diversified operations into chemicals and equipment
  • Attractive dividend income for income‑focused investors

Key Metrics & Analysis

Financial Health

Revenue Growth-23.80%
Profit Margin10.78%
P/E Ratio11.3
ROE10.85%
ROA4.33%
Debt/Equity34.95
P/B Ratio1.1
Op. Cash FlowHK$29.5B
Free Cash FlowHK$4.3B
Industry P/E21.9

Technical Analysis

TrendBullish
RSI70.1
SupportHK$11.61
ResistanceHK$14.59
MA 20HK$12.85
MA 50HK$11.69
MA 200HK$10.36
MACDBullish
VolumeIncreasing
Fear & Greed Index78.16

Valuation

Fair ValueHK$4.66
Target PriceHK$12.07
Upside/Downside-14.96%
GradeOvervalued
TypeValue
Dividend Yield3.27%

Risk Assessment

Beta0.10
Volatility45.65%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.